跳至主要内容
临床试验/NCT03869047
NCT03869047已完成4 期

Dexmedetomidine Added to Bupivacaine Versus Bupivacaine inTransincisionalU/S Guided Quadratus Lumborum Block in Open Renal Surgeries , A New Technique :Prospective, Randomized Double- Blinded Study

Ain Shams University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年3月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
80
试验地点
1
主要终点
First time to analgesic requirement

研究概览

简要总结

The purpose of this study is to compare the addition of dexmedetomidine to bupivacaine versus bupivacaine only in anterior QLblock(transincisional) , where the local anesthetic will be applied before wound closure at the end of surgery through the wound . in combination with general anesthesia in elective open renal surgery with regard to Postoperative pain control,hemodynamic stability, and adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • physical status American Society of Anesthesiologist (ASA) I or II

排除标准

  • Patients refusal
  • A body mass index (BMI) >30 kg/m2
  • ASA physical status >II
  • major illnesses (e.g., cardiac, respiratory, renal, hepatic or neurological)
  • Coagulation abnormalities
  • Infection at the injection site
  • Allergy or contraindications to the drugs used in the study
  • History of drug addiction or alcohol abuse
  • A psychiatric illness, or mental retardation interfering with the evaluation of pain scores or PCA programs .

研究组 & 干预措施

quadratus lumborum block(dexmedetomidine+bupivacaine)

Active Comparator

patients will receive combined general anesthesia and Quadratuslumborum block( transincisional ie before wound closure)with 19 mL of bupivacaine 0.20%plus 1 mic/kg of dexmedetomidine ,total volume 20 ml.

干预措施: Dexmedetomidine +bupivacaine (Drug)

quadratus lumborum block(bupivacaine)

Active Comparator

patients will receive combined general anesthesia and quadratus lumborum block (transincisional) with 20 ml of bupivacaine 0.20%.

干预措施: Bupivacaine (Drug)

结局指标

主要结局

First time to analgesic requirement

时间窗: 1st 24 hour postoperatively

After extubation, an intravenous patient - controlled system, will be connected to the patient (Accufuser plus 100 ml) will be prepared with 60 ml isotonic saline containing 60 mg morphine , it will be programmed to give 0.5 ml bolus dose with lockout interval of 8 minutes. Time to first bolus will be recorded considering extubation time is the zero time

次要结局

  • the secondary outcomes will be the total opioid consumption postoperatively(1st 24 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amin Mohammed Alansary Amin Ahmed Helwa

Assistant professor

Ain Shams University

研究点 (1)

Loading locations...

相似试验